carbamazepine has been researched along with Dyslipidemia in 1 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients who began treatment or whose treatment for dyslipidemia was modified during the study period were excluded from the analysis." | 1.42 | Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests. ( Jiménez-Conde, J; Ley, M; Principe, A; Rocamora, R, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ley, M | 1 |
| Principe, A | 1 |
| Jiménez-Conde, J | 1 |
| Rocamora, R | 1 |
1 other study available for carbamazepine and Dyslipidemia
| Article | Year |
|---|---|
Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests.
Topics: Adult; Anticonvulsants; Carbamazepine; Cholesterol; Dibenzazepines; Dyslipidemias; Epilepsy; Female; | 2015 |